Talo To Acquire Leadingpharm And Tongjuntang
This article was originally published in PharmAsia News
Executive Summary
Talo Pharmaceutical has disclosed a restructuring plan under which the company intends to acquire 100% of Beijing Leadingpharm Medical Technology and the remaining 49% of Hangzhou Tongjuntang.